2021 Virtual World Medical Innovation Forum, Mass General Brigham, Gene and Cell Therapy, VIRTUAL May 19–21, 2021
Reporter: Aviva Lev-Ari, PhD, RN
The 2021 Virtual World Medical Innovation Forum will focus on the growing impact of gene and cell therapy.Senior healthcare leaders from all over look to shape and debate the area of gene and cell therapy. Our shared belief: no matter the magnitude of change, responsible healthcare is centered on a shared commitment to collaborative innovation–industry, academia, and practitioners working together to improve patients’ lives.
About the World Medical Innovation Forum
Mass General Brigham is pleased to present the World Medical Innovation Forum (WMIF) virtual event Wednesday, May 19 – Friday, May 21. This interactive web event features expert discussions of gene and cell therapy (GCT) and its potential to change the future of medicine through its disease-treating and potentially curative properties. The agenda features 150+ executive speakers from the healthcare industry, venture, startups, life sciences manufacturing, consumer health and the front lines of care, including many Harvard Medical School-affiliated researchers and clinicians. The annual in-person Forum will resume live in Boston in 2022. The World Medical Innovation Forum is presented by Mass General Brigham Innovation, the global business development unit supporting the research requirements of 7,200 Harvard Medical School faculty and research hospitals including Massachusetts General, Brigham and Women’s, Massachusetts Eye and Ear, Spaulding Rehab and McLean Hospital. Follow us on Twitter: twitter.com/@MGBInnovation
Accelerating the Future of Medicine with Gene and Cell Therapy What Comes Next
https://worldmedicalinnovation.org/agenda/
Virtual | May 19–21, 2021
#WMIF2021
@MGBInnovation
Leaders in Pharmaceutical Business Intelligence (LPBI) Group
will cover the event in Real Time
Aviva Lev-Ari, PhD, RN
Founder LPBI 1.0 & LPBI 2.0

will be in virtual attendance producing the e-Proceedings
and the Tweet Collection of this Global event expecting +15,000 attendees
@pharma_BI
@AVIVA1950
LPBI’s Eighteen Books in Medicine
https://lnkd.in/ekWGNqA
Among them, books on Gene and Cell Therapy include the following:
Topics for May 19 – 21 include:
Impact on Patient Care – Therapeutic and Potentially Curative GCT Developments
GCT Delivery, Manufacturing – What’s Next
GCT Platform Development
Oncolytic Viruses – Cancer applications, start-ups
Regenerative Medicine/Stem Cells
Future of CAR-T
M&A Shaping GCT’s Future
Market Priorities
Venture Investing in GCT
China’s GCT Juggernaut
Disease and Patient Focus: Benign blood disorders, diabetes, neurodegenerative diseases
Click here for the current WMIF agenda
Plus:
Fireside Chats: 1:1 interviews with industry CEOs/C-Suite leaders including Novartis Gene Therapies, ThermoFisher, Bayer AG, FDA
First Look: 18 briefings on emerging GCT research from Mass General Brigham scientists
Virtual Poster Session: 40 research posters and presenters on potential GCT discoveries from Mass General Brigham
Announcement of the Disruptive Dozen, 12 GCT technologies likely to break through in the next few years
Leave a Reply